acetylcysteine in the treatment of diarrhea caused by rotavirus

Phase 3

• Conditions: Diarrhea caused by rotavirus.; Rotaviral enteritis; A08.0

• Registration Number: IRCT20181208041882N13
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Rotavirus infection has been confirmed in patient.
The age range of the patient is between 6 months and 5 years
Absence of genetic or chronic diseases in patients
Insensitivity to N-acetylcysteine
Do not receive ibuprofen

Exclusion Criteria

Patients who refer after 48 hours from the onset of diarrhea.
Patients who receive ibuprofen.
Hypersensitivity to N-acetylcysteine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Investigation of duration and frequency of diarrhea. Timepoint: Days zero to seven. Method of measurement: Frequency of diarrhea per day and duration of diarrhea.